Memory B cells in transplantation

Transplantation

Volumn 99, Issue 1, 2015, Pages 21-28

  Chong, Anita S ^a   Sciammas, Roger ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD27 ANTIGEN; CD38 ANTIGEN; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; ALLOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ALLOIMMUNITY; ANTIGEN SPECIFICITY; B LYMPHOCYTE ACTIVATION; CELL COUNT; CELL FATE; CELL HETEROGENEITY; CELL MIGRATION; CELL POPULATION; DOWN REGULATION; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM SURVIVAL; MEMORY CELL; NONHUMAN; PHENOTYPE; PLASMA CELL; REVIEW; TRANSPLANTATION; ADVERSE EFFECTS; ALLOGRAFT; ANIMAL; B LYMPHOCYTE; BLOOD; DRUG EFFECTS; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ORGAN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ALLOGRAFTS; ANIMALS; B-LYMPHOCYTES; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNITY, HUMORAL; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; ORGAN TRANSPLANTATION; PHENOTYPE; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 84920114658     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000545     Document Type: Review

References (71)

1. Reed EF, Rao P, Zhang Z, et al. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation. Am J Transplant 2013;13:3050.
2. Loupy A, Jordan SC. Transplantation: donor-specific HLA antibodies and renal allograft failure. Nat Rev Nephrol 2013;9:130.
3. Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl JMed 2013;369:1215.
4. Mohan S, Palanisamy A, Tsapepas D, et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012; 23:2061.
5. Burns AM, Chong AS. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol 2011;186:214.
6. Burns AM, Ma L, Li Y, et al. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol 2009; 182:1314.
7. CarrollMC, Isenman DE. Regulation of humoral immunity by complement. Immunity 2012;37:199.
8. Nimmerjahn F, Ravetch JV. Antibody-mediated modulation of immune responses. Immunol Rev 2010;236:265.
9. Wasowska BA, Lee CY, Halushka MK, et al. New concepts of complement in allorecognition and graft rejection. Cell Immunol 2007;248:18.
10. Stegall MD, Moore N, Taner T, et al. Down-regulating humoral immune responses: implications for organ transplantation. Transplantation 2014;97:247.
11. Vincent FB, Saulep-Easton D, FiggettWA, et al. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 2013;24:203.
12. Goodnow CC, Vinuesa CG, Randall KL, et al. Control systems and decision making for antibody production. Nat Immunol 2010;11:681.
13. Sciammas R, Davis MM. Blimp-1; immunoglobulin secretion and the switch to plasma cells. Curr Top Microbiol Immunol 2005;290:201.
14. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005;5:230.
15. Tarlinton DM, Hodgkin PD. Targeting plasma cells in autoimmune diseases. J Exp Med 2004;199:1451.
16. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007;27:190.
17. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008;8:22.
18. Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol 2012;30:429.
19. Good-Jacobson KL, Shlomchik MJ. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J Immunol 2010;185:3117.
20. Good-Jacobson KL, Tarlinton DM. Multiple routes to B-cell memory. Int Immunol 2012;24:403.
21. Tarlinton D, Good-Jacobson K. Diversity among memory B cells: origin, consequences, and utility. Science 2013;341:1205.
22. Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998;10:252.
23. Cunningham AF, Gaspal F, Serre K, et al. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol 2007;178:6200.
24. Smith KG, Hewitson TD, Nossal GJ, et al. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol 1996;26:444.
25. Xiang Z, Cutler AJ, Brownlie RJ, et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 2007;8:419.
26. Chu VT, Beller A, Rausch S, et al. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity 2014;40:582.
27. Chu VT, Frohlich A, Steinhauser G, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 2011; 12:151.
28. Denzel A, Maus UA, Rodriguez Gomez M, et al. Basophils enhance immunological memory responses. Nat Immunol 2008;9:733.
29. Valujskikh A, Bromberg JS. The house that Jack built: expanding the concept of plasma cell niches. Am J Transplant 2013;13:533.
30. Winter O, Moser K, Mohr E, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 2010;116:1867.
31. Pelletier N, McHeyzer-Williams LJ, Wong KA, et al. Plasma cells negatively regulate the follicular helper T cell program. Nat Immunol 2010;11:1110.
32. PurthaWE, Tedder TF, Johnson S, et al.Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med 2011;208:2599.
33. Smith KG, Light A, Nossal GJ, et al. The extent of affinitymaturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J 1997;16:2996.
34. Takemori T, Kaji T, Takahashi Y, et al. Generation of memory B cells inside and outside germinal centers. Eur J Immunol 2014;44:1258.
35. Taylor JJ, Jenkins MK, Pape KA. Heterogeneity in the differentiation and function of memory B cells. Trends Immunol 2012;33:590.
36. Constant S, Sant'Angelo D, Pasqualini T, et al. Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J Immunol 1995;154:4915.
37. Constant S, Schweitzer N, West J, et al. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 1995;155:3734.
38. Batista FD, Neuberger MS. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity 1998;8:751.
39. Dintzis HM, Dintzis RZ, Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A 1976;73:3671.
40. Kouskoff V, Famiglietti S, Lacaud G, et al. Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med 1998;188:1453.
41. Mongini PK, Blessinger CA, Dalton JP. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgMcross-linking ligands. J Immunol 1991;146:1791.
42. Myers CD, Kriz MK, Sullivan TJ, et al. Antigen-induced changes in phospholipid metabolism in antigen-binding B lymphocytes. J Immunol 1987;138:1705.
43. Kometani K, Nakagawa R, Shinnakasu R, et al. Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity 2013;39:136.
44. Horikawa K, Martin SW, Pogue SL, et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med 2007;204:759.
45. Martin SW, Goodnow CC. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol 2002;3:182.
46. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993;54:229.
47. Radic M. Tracking and trapping somatic mutations in Ig genes. J Immunol 2008;180:5763.
48. Tarlinton DM. Evolution in miniature: selection, survival and distribution of antigen reactive cells in the germinal centre. Immunol Cell Biol 2008;86:133.
49. Smith KG, Light A, O'Reilly LA, et al. bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J Exp Med 2000;191:475.
50. Vikstrom I, Carotta S, Luthje K, et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 2010;330:1095.
51. Anderson SM, TomaykoMM, Ahuja A. Newmarkers formurine memory B cells that define mutated and unmutated subsets. J ExpMed 2007;204:2103.
52. Dogan I, Bertocci B, Vilmont V, et al. Multiple layers of B cell memory with different effector functions. Nat Immunol 2009;10:1292.
53. Kaji T, Ishige A, Hikida M, et al. Distinct cellular pathways select germlineencoded and somaticallymutated antibodies into immunological memory. J ExpMed 2012;209:2079.
54. Pape KA, Taylor JJ, Maul RW, et al. Different B cell populations mediate early and latememory during an endogenous immune response. Science 2011;331:1203.
55. Zuccarino-Catania GV, Sadanand S, Weisel FJ, et al. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat Immunol 2014;15:631.
56. Taylor JJ, Pape KA, Jenkins MK. A germinal center-independent pathway generates unswitchedmemory B cells early in the primary response.JExp Med 2012;209:597.
57. Kwun J, Oh BC, Gibby AC, et al. Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. Am J Transplant 2012;12:2641.
58. Chen J, Yin H, Xu J, et al. Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig. Am J Transplant 2013;13:2280.
59. Sicard A, Phares TW, Yu H, et al. The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients. Am J Transplant 2012;12:1708.
60. Zachary AA, Kopchaliiska D, Montgomery RA, et al. HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007;83:982.
61. Zachary AA, Kopchaliiska D, Montgomery RA, et al. HLA-specific B cells: II. Application to transplantation. Transplantation 2007;83:989.
62. Heidt S, Roelen DL, de Vaal YJ, et al. A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals. Am J Transplant 2012;12:1469.
63. Lynch RJ, Silva IA, Chen BJ, et al. Cryptic B cell response to renal transplantation. Am J Transplant 2013;13:1713.
64. Han M, Rogers JA, Lavingia B, et al. Peripheral blood B cells producing donor-specific HLA antibodies in vitro. Hum Immunol 2009;70:29.
65. Crotty S, Aubert RD, Glidewell J, et al. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004;286:111.
66. Turner AP, Shaffer VO, Araki K, et al. Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant 2011;11:613.
67. Wrammert J, Smith K, Miller J, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008;453:667.
68. Cowan M, Chon WJ, Desai A, et al. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation 2014;97:846.
69. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011;12:786.
70. Stohl W, Hilbert DM. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol 2012;30:69.
71. Ejaz NS, Alloway RR, Halleck F, et al. Review of bortezomib treatment of antibody-mediated rejection in renal transplantation. Antioxid Redox Signal 2014.